Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients

Cell Transplantation

Volumn 23, Issue 6, 2014, Pages 729-745

  El Kheir, Wael Abo ^a   Gabr, Hala ^b   Awad, Mohamed Reda ^c   Ghannam, Osama ^c   Barakat, Yousef ^c   Farghali, Haithem A M A ^b   El Maadawi, Zeinab M ^b   Ewes, Ibrahim ^c   Sabaawy, Hatem E ^b,d  

^a MILITARY MEDICAL ACADEMY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c AL AZHAR UNIVERSITY   (Egypt)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cell therapy; Clinical trial; Motor and sensory function; Physical therapy; Spinal cord injury (SCI)

Indexed keywords

ADHERENT CELL; ADIPOCYTE; ADOLESCENT; ADULT; AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CARTILAGE CELL; CHRONIC PAIN; CONTROLLED STUDY; DISEASE DURATION; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL INDEPENDENCE MEASURE; FUNCTIONAL STATUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STROMA CELL; MOTOR PERFORMANCE; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCYTE; PARALYSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; SINGLE BLIND PROCEDURE; SPINAL CORD INJURY; AUTOTRANSPLANTATION; BIOLOGICAL THERAPY; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CLINICAL TRIAL; CYTOLOGY; KINESIOTHERAPY; MIDDLE AGED; NERVE CELL; PATHOPHYSIOLOGY; SPINAL CORD INJURIES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL- AND TISSUE-BASED THERAPY; CHRONIC DISEASE; EVOKED POTENTIALS, SOMATOSENSORY; EXERCISE THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; SINGLE-BLIND METHOD; SPINAL CORD INJURIES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84898896566     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368913X664540     Document Type: Article

References (36)

1. Amariglio, N.; Hirshberg, A.; Scheithauer, B. W.; Cohen, Y.; Loewenthal, R.; Trakhtenbrot, L.; Paz, N.; Koren-Michowitz, M.; Waldman, D.; Leider-Trejo, L.; Toren, A.; Constantini, S.; Rechavi, G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 6(2):e1000029; 2009.
2. Anderson, K. D. Targeting recovery: Priorities of the spinal cord-injured population. J. Neurotrauma 21(10):1371-1383; 2004.
3. Arnhold, S.; Klein, H.; Klinz, F. J.; Absenger, Y.; Schmidt, A.; Schinkothe, T.; Brixius, K.; Kozlowski, J.; Desai, B.; Bloch, W.; Addicks, K. Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. Eur. J. Cell Biol. 85(6):551-565; 2006.
4. Barnabe-Heider, F.; Goritz, C.; Sabelstrom, H.; Takebayashi, H.; Pfrieger, F. W.; Meletis, K.; Frisen, J. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 7(4):470-482; 2010.
5. Blesch, A.; Tuszynski, M. H. Spinal cord injury: Plasticity, regeneration and the challenge of translational drug development. Trends Neurosci. 32(1):41-47; 2009.
6. Cho, K. J.; Trzaska, K. A.; Greco, S. J.; McArdle, J.; Wang, F. S.; Ye, J. H.; Rameshwar, P. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 23(3):383-391; 2005.
7. Crigler, L.; Robey, R. C.; Asawachaicharn, A.; Gaupp, D.; Phinney, D. G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. 198(1):54-64; 2006.
8. Deda, H.; Inci, M. C.; Kurekci, A. E.; Kayihan, K.; Ozgun, E.; Ustunsoy, G. E.; Kocabay, S. Treatment of chronic spinal cord injured patients with autologous bone marrowderived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 10(6):565-574; 2008.
9. Ding, D. C.; Shyu, W. C.; Lin, S. Z. Mesenchymal stem cells. Cell Transplant. 20(1):5-14; 2011.
10. Fawcett, J. W.; Curt, A.; Steeves, J. D.; Coleman, W. P.; Tuszynski, M. H.; Lammertse, D.; Bartlett, P. F.; Blight, A. R.; Dietz, V.; Ditunno, J.; Dobkin, B. H.; Havton, L. A.; Ellaway, P. H.; Fehlings M. G.; Privat, A.; Grossman, R.; Guest, J. D.; Kleitman, N.; Nakamura, M.; Gaviria, M.; Short, D. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45(3):190-205; 2007.
11. Guest, J. D.; Hiester, E. D.; Bunge, R. P. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192(2):384-393; 2005.
12. Hofstetter, C. P.; Schwarz, E. J.; Hess, D.; Widenfalk, J.; El Manira, A.; Prockop, D. J.; Olson, L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA 99(4):2199-2204; 2002.
13. Holden, M. K.; Gill, K. M.; Magliozzi, M. R. Gait assessment for neurologically impaired patients. Standards for outcome assessment. Phys. Ther. 66(10):1530-1539; 1986.
14. Jones, E.; McGonagle, D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology 47(2):126-131; 2008.
15. Karp, J. M.; Leng Teo, G. S. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 4(3):206-216; 2009.
16. Kirshblum, S.; Millis, S.; McKinley, W.; Tulsky, D. Late neurologic recovery after traumatic spinal cord injury. Arch. Phys. Med. Rehabil. 85(11):1811-1817; 2004.
17. Kishk, N. A.; Abokrysha, N. T.; Gabr, H. Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection. J. Clin. Neurosci. 20(2):310-312; 2013.
18. Kishk, N. A.; Gabr, H.; Hamdy, S.; Afifi, L.; Abokresha, N.; Mahmoud, H.; Wafaie, A.; Bilal, D. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil. Neural Repair 24(8):702-708; 2010.
19. Lammertse, D.; Tuszynski, M. H.; Steeves, J. D.; Curt, A.; Fawcett, J. W.; Rask, C.; Ditunno, J. F.; Fehlings, M. G.; Guest, J. D.; Ellaway, P. H.; Kleitman, N.; Blight, A. R.; Dobkin, B. H.; Grossman, R.; Katoh, H.; Privat, A.; Kalichman, M. International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Clinical trial design. Spinal Cord 45(3):232-242; 2007.
20. Lee, J.; Kuroda, S.; Shichinohe, H.; Ikeda, J.; Seki, T.; Hida, K.; Tada, M.; Sawada, K.; Iwasaki, Y. Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology 23(3):169-180; 2003.
21. Mackay-Sim, A.; Feron, F.; Cochrane, J.; Bassingthwaighte, L.; Bayliss, C.; Davies, W.; Fronek, P.; Gray, C.; Kerr, G.; Licina, P.; Nowitzke, A.; Perry, C.; Silburn, P. A.; Urquhart, S.; Geraghty, T. Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain 131(Pt 9):2376-2386; 2008.
22. Marino, R. J.; Graves, D. E. Metric properties of the ASIA motor score: Subscales improve correlation with functional activities. Arch. Phys. Med. Rehabil. 85(11):1804-1810; 2004.
23. Meissner, A.; Jaenisch, R. Mammalian nuclear transfer. Dev. Dyn. 235(9):2460-2469; 2006.
24. Moviglia, G. A.; Varela, G.; Brizuela, J. A.; Moviglia Brandolino, M. T.; Farina, P.; Etchegaray, G.; Piccone, S.; Hirsch, J.; Martinez, G.; Marino, S.; Deffain, S.; Coria, N.; Gonzáles, A.; Sztanko, M.; Salas-Zamora, P.; Previgliano, I.; Aingel, V.; Farias, J.; Gaeta, C. A.; Saslavsky, J.; Blasseti, N. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord 47(6):499-503; 2009.
25. Nauta, A. J.; Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10):3499-3506; 2007.
26. Pal, R.; Venkataramana, N. K.; Bansal, A.; Balaraju, S.; Jan, M.; Chandra, R.; Dixit, A.; Rauthan, A.; Murgod, U.; Totey, S. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: A pilot clinical study. Cytotherapy 11(7):897-911; 2009.
27. Pang, Z. P.; Yang, N.; Vierbuchen, T.; Ostermeier, A.; Fuentes, D. R.; Yang, T. Q.; Citri, A.; Sebastiano, V.; Marro, S.; Sudhof, T. C.; Wernig, M. Induction of human neuronal cells by defined transcription factors. Nature 476(7359):220-223; 2011.
28. Patel, N.; Klassert, T. E.; Greco, S. J.; Patel, S. A.; Munoz, J. L.; Reddy, B. Y.; Bryan, M.; Campbell, N.; Kokorina, N.; Sabaawy, H. E.; Rameshwar, P. Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: Implication for spinal cord injury in zebrafish. Stem Cells Dev. 21(2):308-320; 2012.
29. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147; 1999.
30. Prockop, D. J. Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol. Ther. 17(6):939-946; 2009.
31. Sasaki, M.; Honmou, O.; Akiyama, Y.; Uede, T.; Hashi, K.; Kocsis, J. D. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia 35(1):26-34; 2001.
32. Schinkothe, T.; Bloch, W.; Schmidt, A. In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev. 17(1):199-206; 2008.
33. Syková, E.; Homola, A.; Mazanec, R.; Lachmann, H.; Konrádová, S. L.; Kobylka, P.; Pádr, R.; Neuwirth, J.; Komrska, V.; Vávra, V.; Stulík, J.; Bojar, M. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 15(8-9):675-687; 2006.
34. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676; 2006.
35. Tetzlaff, W.; Okon, E. B.; Karimi-Abdolrezaee, S.; Hill, C. E.; Sparling, J. S.; Plemel, J. R.; Plunet, W. T.; Tsai, E. C.; Baptiste, D.; Smithson, L. J.; Kawaja, M. D.; Fehlings, M. G.; Kwon, B. K. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28(8):1611-1682; 2010.
36. Thuret, S.; Moon, L. D.; Gage, F. H. Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 7(8):628-643; 2006.